Theo Website.jpg

Theo Dinklo, Phd

Theo joined Synerkine Pharma from the start in April 2019 as Director of Translational Research. He is responsible for the preclinical characterization and development of Synerkine Pharma’s key project.

Prior to joining Synerkine Pharma, Theo gained 15 years of in drug discovery and preclinical safety experience at Janssen Pharmaceutica (Belgium) and Roche (Switzerland). He has a background in electrophysiology and implemented these techniques in drug discovery screening. As Principal Scientist in safety pharmacology at Roche, he was responsible for the early CNS safety screening and regulatory studies for entry into human, as well as CNS-related concerns during preclinical drug development. With his knowledge of GLP and drug abuse liability assessment, he further supported several late stage projects passing this regulatory hurdle.

Theo was trained as a biologist at the Radboud University (Nijmegen) and holds a PhD in Life Sciences from the university of Groningen (2005).